Veradermics Statistics
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
110.95+1.99 (+1.83%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Veradermics by the numbers
Veradermics has a market capitalization of $4.64 billion based on 41.78M shares outstanding. With trailing EPS of $-4.24, Veradermics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.2% above its 50-day average and 23.1% above its 200-day average.
Average daily trading volume is 730.99K shares, or about $81.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MANE valuation vs. peer median
| Metric | MANE | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.64B | $4.84B | -4% |
| Avg. volume | 730.99K | 1.75M | -58% |
Peer median across 8 companies: DNTH, EWTX, INDV, ERAS, ABCL, TVTX, GRFS, COGT.
Valuation
- Market cap
- $4.64B
- EPS (TTM)
- $-4.24
- Shares outstanding
- 41.78M
Price and trading
- Previous close
- 108.96
- Open
- 108.92
- Day range
- 108.84 – 113.43
- 52-week range
- 32.00 – 131.24
- 50-day moving average
- 107.54
- Beta
- —
- Volume
- 655.07K
- Average volume
- 730.99K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 4.64B
- Forward Pe
- -41.29
- Eps
- -4.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 131.24
- Week52 Low
- 32.00
- Avg Volume
- 730.99K
- Shares Outstanding
- 41.78M
- Ma50
- 107.54
- Ma200
- 90.15
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -15.46%
- Pct From52w Low
- 246.72%